Whether kidney failure can be reversed depends almost entirely on one question: is the damage acute or chronic? Acute kidney injury, where the kidneys shut down suddenly over hours or days, is often reversible. Chronic kidney disease, where function erodes over months or years, generally is not reversible, but it can be slowed dramatically and sometimes stabilized. Understanding which situation you’re dealing with changes everything about what’s possible.
Acute Kidney Injury: The Reversible Kind
Acute kidney injury (AKI) happens when something abruptly cuts blood flow to the kidneys, blocks urine output, or exposes the kidneys to a toxic substance. Common triggers include severe dehydration, major surgery, sepsis, and certain medications. Because the underlying kidney tissue may still be structurally intact, removing the cause often allows the kidneys to repair themselves.
Recovery rates for AKI vary widely depending on severity. Studies report complete recovery anywhere from 33% to 90% of cases when all stages of AKI are included. For the most severe cases requiring temporary dialysis, between 60% and 100% of patients eventually come off dialysis, though up to 30% may still need it at the 90-day mark. The timeline matters: kidney specialists now distinguish between AKI (the first 7 days), acute kidney disease (days 7 through 90), and chronic kidney disease (beyond 90 days). The longer the kidneys take to recover, the higher the risk of permanent damage.
Risk factors for not recovering include older age, pre-existing health conditions, and how sick you were when the injury occurred. Even after a full recovery from AKI, your risk of developing chronic kidney disease later is elevated, so follow-up monitoring of kidney function is important.
Chronic Kidney Disease: Slowing the Decline
Chronic kidney disease (CKD) involves gradual, structural damage to the tiny filtering units inside the kidneys. Once those units are scarred or destroyed, they don’t regenerate. This is why CKD is staged by how much filtering capacity remains, measured as an estimated glomerular filtration rate (eGFR). Stage 1 means your kidneys still filter well despite early signs of damage; stage 5 means they’ve lost so much function that dialysis or a transplant becomes necessary.
The goal with CKD isn’t reversal in most cases. It’s stopping or dramatically slowing the progression so you never reach stage 5. Many people diagnosed at stages 2 or 3 can stay stable for decades with the right management. The strategies below are what make that possible.
Blood Pressure and Kidney-Protective Medications
High blood pressure is both a cause and a consequence of kidney disease, and controlling it is the single most important medical intervention for slowing CKD. A class of blood pressure medications (ACE inhibitors and ARBs) does double duty: they lower blood pressure and reduce the pressure inside the kidney’s filtering units specifically. Guidelines recommend these drugs for anyone with CKD and protein in their urine, even if their blood pressure is otherwise normal.
A newer class of medications originally designed for type 2 diabetes has proven to be remarkably effective at protecting kidneys regardless of diabetes status. In a major clinical trial, one of these drugs reduced the risk of reaching end-stage kidney disease by 32% compared to placebo. A second trial in a broader population of CKD patients, including those without diabetes, found a 44% reduction in the combined risk of severe kidney function decline, kidney failure, or kidney-related death. These are some of the largest treatment effects seen in kidney medicine, and these drugs are now recommended as standard therapy for many people with CKD.
Monitoring Protein in Your Urine
One of the earliest and most actionable signs of kidney damage is protein leaking into your urine, measured by a urine albumin-to-creatinine ratio (UACR). A result under 30 mg/g is considered normal. But research in diabetic patients shows that even within the “normal” range, a UACR above roughly 10 mg/g predicts a significantly higher chance of CKD progressing. For women, that threshold may be even lower, around 8 mg/g.
This means that if your UACR is creeping upward, even if it hasn’t crossed the traditional 30 mg/g cutoff, it’s a signal to tighten blood pressure control, manage cholesterol more aggressively, and intensify lifestyle changes. Tracking this number over time gives you and your doctor one of the clearest pictures of whether your kidneys are stable or deteriorating.
Medications That Can Harm Your Kidneys
If you have any degree of kidney disease, certain common over-the-counter painkillers are not safe. NSAIDs, which include ibuprofen (Advil, Motrin), naproxen (Aleve), and prescription options like celecoxib (Celebrex) and diclofenac (Voltaren), reduce blood flow to the kidneys and can accelerate damage. Low-dose aspirin (81 to 325 mg daily) used as a blood thinner is generally fine, but aspirin taken at higher doses for pain relief is not.
This catches many people off guard because these are medications they’ve used casually for years. Acetaminophen (Tylenol) is typically the safer alternative for pain, though your doctor can guide dosing based on your kidney function level.
Lifestyle Changes That Protect Kidney Function
Diet plays a significant role. Reducing sodium intake lowers blood pressure and decreases the workload on your kidneys. Limiting protein intake, counterintuitively, can also help because protein metabolism produces waste products that damaged kidneys struggle to filter. The right level of protein restriction depends on your CKD stage, so this is worth discussing with a dietitian who specializes in kidney disease.
Smoking increases the risk of developing protein in the urine, a hallmark of kidney damage. In a large study of healthy middle-aged workers, those who continued smoking were about 2.5 times more likely to develop proteinuria over six years compared to nonsmokers. Those who quit brought their risk back down close to the nonsmoking baseline. Proteinuria, in turn, accelerated kidney function decline: men who developed it lost an additional 3.4 mL/min of filtration capacity over the study period compared to those who didn’t. The message is straightforward: quitting smoking removes one of the modifiable accelerators of kidney disease.
Maintaining a healthy weight, staying physically active, and managing blood sugar if you have diabetes are equally important. Diabetes and high blood pressure together account for the majority of CKD cases, so controlling these conditions is, in practical terms, how most people protect their remaining kidney function.
When Kidneys Fail Completely
If CKD progresses to stage 5 despite treatment, the two options are dialysis and kidney transplantation. Dialysis filters your blood mechanically, either at a center (hemodialysis, typically three times per week) or at home using the lining of your abdomen (peritoneal dialysis, done daily). It replaces the kidneys’ filtering function but not their hormonal roles, so it’s a life-sustaining treatment rather than a cure.
Transplantation comes closer to a true reversal. A functioning transplanted kidney restores filtration, eliminates the need for dialysis, and dramatically improves survival. Even among people over 70, five-year survival after a kidney transplant is 80%, compared to 53% for those who remain on dialysis. Transplant recipients take immune-suppressing medications for life to prevent rejection, but most people experience a quality of life far closer to normal than dialysis provides.
Cell Therapy: Where Things Stand
Researchers are actively exploring whether injecting certain types of cells into damaged kidneys can stimulate repair. Early-phase clinical trials have tested stem cells derived from bone marrow for acute kidney injury, with mixed results. One trial in patients with severe AKI showed improved kidney filtration over the first few months, but a larger trial using stem cells after cardiac surgery found no significant benefit over placebo.
For chronic kidney disease, a therapy using a patient’s own kidney cells (reinjected after being grown in a lab) showed a statistically significant slowing of kidney function decline in patients with moderate to severe diabetic CKD. Another trial using a different cell type reduced the combined risk of dialysis or death at one year, though it didn’t improve filtration rate directly. These are promising signals, but all remain in early trial phases. No cell therapy is currently available as a standard treatment for kidney failure.